Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyOTTAIANO, Alessandro; MOLLO, Ernesto; BRYCE, Jane et al.Cancer immunology and immunotherapy. 2005, Vol 54, Num 1, pp 44-50, issn 0340-7004, 7 p.Article

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumorsFURY, Matthew G; KRUG, Lee M; AZZOLI, Christopher G et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 671-677, issn 0344-5704, 7 p.Article

Final results of a phase I and pharmacokinetic study of _γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumorsJOHANSEN, Mary; ZUKOWSKI, Thomas; HOFF, Paulo M et al.Cancer chemotherapy and pharmacology. 2004, Vol 53, Num 5, pp 370-376, issn 0344-5704, 7 p.Article

Hematopoetic stem cell transplantation for solid tumors in EuropeGRATWOHL, A; BALDOMERO, H; DEMIRE, T et al.Annals of oncology. 2004, Vol 15, Num 4, pp 653-660, issn 0923-7534, 8 p.Article

Self-renewal and solid tumor stem cellsAL-HAJJ, Muhammad; CLARKE, Michael F.Oncogene (Basingstoke). 2004, Vol 23, Num 43, pp 7274-7282, issn 0950-9232, 9 p.Article

Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancyBARNACLE, A. M; MCHUGH, Kieran.Pediatric blood & cancer. 2006, Vol 46, Num 2, pp 127-134, issn 1545-5009, 8 p.Article

The role of proteasome inhibitors in solid tumors : Proteasome inhibitionPARK, David J; LENZ, Heinz-Josef.Annals of medicine (Helsinki). 2004, Vol 36, Num 4, pp 296-303, issn 0785-3890, 8 p.Article

Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumorsSCHWARTZ, Gary K; CARVAJAL, Richard D; MIDGLEY, Rachel et al.Investigational new drugs. 2013, Vol 31, Num 2, pp 370-380, issn 0167-6997, 11 p.Article

Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumorsMURAKAMI, Haruyasu; UEDA, Yutaka; SHIMOYAMA, Tatsu et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 5, pp 1119-1128, issn 0344-5704, 10 p.Article

Conversion of the anti-tumor agent tasidotin (ILX651 ) to its active metabolite by prolyl oligopeptidaseDEUTCH, Charles E; KRUMBHOLZ, Roy; SCHMID, Steve M et al.Enzyme and microbial technology. 2010, Vol 46, Num 3-4, pp 246-251, issn 0141-0229, 6 p.Article

Pharmacokinetics of temozolomide administered in combination with O⁶-benzylguanine in children and adolescents with refractory solid tumorsMEANY, Holly J; WARREN, Katherine E; FOX, Elizabeth et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 1, pp 137-142, issn 0344-5704, 6 p.Article

Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patientsPUGLISI, Fabio; DEROMA, Laura; BECCAGLIA, Patrizia et al.Critical reviews in oncology/hematology. 2009, Vol 69, Num 2, pp 175-182, issn 1040-8428, 8 p.Article

Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents : a review of clinical trialsTAKIMOTO, Chris H; AWADA, Ahmad.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 4, pp 535-548, issn 0344-5704, 14 p.Article

Antiproliferative activity of 2-alkyl-4-halopiperidines and 2 -alkyl -4 -halo -1,2,5,6 -tetrahydropyridines in solid tumor cell linesLEON, Leticia G; CARBALLO, Rubén M; VEGA-HERNANDEZ, Maria C et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 10, pp 2681-2684, issn 0960-894X, 4 p.Article

A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumorsAMARANTIDIS, K; HOUHOULI, K; PAPATHEODOROU, K et al.Oncology research. 2006, Vol 16, Num 6, pp 281-287, issn 0965-0407, 7 p.Article

Down's syndrome-associated Single Minded 2 gene as a pancreatic cancer drug therapy targetDEYOUNG, Maurice Phil; TRESS, Matthew; NARAYANAN, Ramaswamy et al.Cancer letters. 2003, Vol 200, Num 1, pp 25-31, issn 0304-3835, 7 p.Article

A phase 1 study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumorsMITA, M; GORDON, M; REJEB, N et al.Targeted oncology. 2014, Vol 9, Num 3, pp 215-224, issn 1776-2596, 10 p.Article

Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumorsSALAZAR, Ramon; MORALES, Serafin; GIL-MARTIN, Marta et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1205-1215, issn 0344-5704, 11 p.Article

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumorsRODON, Jordi; BRANA, Irene; ESKENS, Ferry et al.Investigational new drugs. 2014, Vol 32, Num 4, pp 670-681, issn 0167-6997, 12 p.Article

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsSUNAKAWA, Yu; FURUSE, Junji; OKUSAKA, Takuji et al.Investigational new drugs. 2014, Vol 32, Num 1, pp 104-112, issn 0167-6997, 9 p.Article

A phase I study of sunitinib combined with modified FOLFOX6 in patients with advanced solid tumorsLEONG, S; ECKHARDT, S. G; LOCKHART, A. C et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 65-74, issn 0344-5704, 10 p.Article

A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumorsRAMASWAMY, Bhuvaneswari; BEKAII-SAAB, Tanios; WRIGHT, John J et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 1, pp 151-158, issn 0344-5704, 8 p.Article

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapyAWADA, Ahmad; PICCART, Martine J; JONES, Suzanne F et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 3, pp 417-425, issn 0344-5704, 9 p.Article

Body composition by dilution of deuterium oxide in Mexican children with lymphoma and solid tumorsBARBOSA-CORTES, Lourdes; TAPIA-ROJAS, Marisa; LOPEZ-AGUILAR, Enrique et al.Nutrition (Burbank, Los Angeles County, Calif.). 2007, Vol 23, Num 10, pp 739-744, issn 0899-9007, 6 p.Article

A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumorsSARIDAKI, Zacharenia; BOZIONELOU, Vasiliki; MAVROUDIS, Dimitris et al.Oncology. 2007, Vol 72, Num 1-2, pp 45-50, issn 0030-2414, 6 p.Article